Literature DB >> 30044243

Billing Practices Among US Tobacco Use Treatment Providers.

Erika Litvin Bloom1, Michael V Burke, Chris Kotsen, Adam O Goldstein, Carol Ripley-Moffitt, Michael B Steinberg, Mary Dailey, Laura E Hunt, Matthew P Bars.   

Abstract

OBJECTIVES: The US Affordable Care Act (ACA) now requires almost all health insurance plans to cover tobacco use treatment (TUT), but TUT remains underutilized.
METHODS: We conducted an anonymous online survey of US TUT providers in 2016 regarding their billing practices.
RESULTS: Participants (n = 131) provided services primarily in medical and behavioral health settings and were from a variety of professions. Most provided intensive individual (>15 minutes per session) and/or group counseling. Although most reported that their organization accepted at least 1 form of insurance, only 34% reported that TUT services were billed, with about equal proportions endorsing billing under their own independent tax ID and "incident to" billing under a supervisor. Half of billers (52%) reported using at least 1 Current Procedural Terminology code. The most common codes were 99406 and 99407, but 18 unique codes were specified. Themes of qualitative responses (n = 101) included concern about how to initiate and sustain adequate reimbursement, and experiences with billing not being "worth" the time or effort.
CONCLUSIONS: Overall, results demonstrate a need for providers, administrators, and billing managers to work collaboratively. Even with the ACA mandate, and consistent with prior reports, reimbursement rates may be inadequate for intensive counseling. Areas for advocacy include recognizing that TUT requires similar intensity, expertise, and reimbursement as other substance use disorders and chronic medical conditions; giving Tobacco Treatment Specialists the ability to bill independently; and improving coordination between intensive therapies validated in research and "real-world" logistics.

Entities:  

Mesh:

Year:  2018        PMID: 30044243     DOI: 10.1097/ADM.0000000000000423

Source DB:  PubMed          Journal:  J Addict Med        ISSN: 1932-0620            Impact factor:   3.702


  3 in total

1.  Cost-effectiveness of Implementing Smoking Cessation Interventions for Patients With Cancer.

Authors:  Douglas E Levy; Susan Regan; Giselle K Perez; Alona Muzikansky; Emily R Friedman; Julia Rabin; Nancy A Rigotti; Jamie S Ostroff; Elyse R Park
Journal:  JAMA Netw Open       Date:  2022-06-01

2.  Reach and effectiveness of the NCI Cancer Moonshot-funded Cancer Center Cessation Initiative.

Authors:  Heather D'Angelo; Sarah D Hohl; Betsy Rolland; Robert T Adsit; Danielle Pauk; Michael C Fiore; Timothy B Baker
Journal:  Transl Behav Med       Date:  2022-05-26       Impact factor: 3.626

3.  Rapid Scaling Up of Telehealth Treatment for Tobacco-Dependent Cancer Patients During the COVID-19 Outbreak in New York City.

Authors:  Chris Kotsen; Deepika Dilip; Lisa Carter-Harris; Maureen O'Brien; Charles W Whitlock; Suhana de Leon-Sanchez; Jamie S Ostroff
Journal:  Telemed J E Health       Date:  2020-07-09       Impact factor: 3.536

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.